We are live on
!
Find out more
EPIX
ESSA Pharma
EPIX
EPIX
Delisted
EPIX was delisted on the 8th of October, 2025.
33 hedge funds and large institutions have $297M invested in ESSA Pharma in 2024 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 10 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
78% more call options, than puts
Call options by funds: $492K | Put options by funds: $277K
50% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 4
16% more capital invested
Capital invested by funds: $257M → $297M (+$40.4M)
6% more funds holding
Funds holding: 31 → 33 (+2)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
9.06% less ownership
Funds ownership: 88.26% → 79.2% (-9.1%)
50% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 10
Holders
33
Holders Change
+2
Holders Change %
+6.45%
% of All Funds
0.48%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
6
Increased
5
Reduced
10
Closed
4
Calls
$492K
Puts
$277K
Net Calls
+$215K
Net Calls Change
+$16K
Top Buyers
Top Sellers
| 1 |
Morgan Stanley
New York
|
-$36.6M |
| 2 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$6.44M |
| 3 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$2.46M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$1.98M |
| 5 |
D.E. Shaw & Co
New York
|
-$1.17M |
